# OnCo record d-alba (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/d-alba/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "d-alba", "NCT02744768" ;
  schema:name "D-ALBA (GIMEMA LAL2116)"@en ;
  schema:description "The trial that showed Ph-positive ALL can be treated with a pill plus an immunotherapy and no chemotherapy, with 95% of patients alive at 18 months."@en ;
  schema:url <https://onco.cc/trials/d-alba/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02744768>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2016272> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2017-05-31" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/bcr-abl/>, <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/gimema/> ;
  onco:terms <https://onco.cc/terms/ph-positive-all/> .